Dexmetedomedine is one of 30 small molecule programs targeting Surgery. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
36 competitors in Surgery
Journavx
Alfenta
Neo-Synephrine
Nubain
Marinol
Desferal
Levophed
Cardene
Tukysa
Senna
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details